Skip to main content

Risk Factors for Diabetic Ketoacidosis (DKA) for Patients on Sodium/Glucose Cotransporter-2 inhibitor (SGLT2i) Therapy - Poster

Dr Jack Colley,  Dr Augustin Brooks

Department of Diabetes and Endocrinology, Royal Bournemouth Hospital

Related Event
ABCD Conference 2020
Resource taxonomy
Clinical taxonomy
Listing status